SynsoryBio
YC W24Boston, US · Founded 2023 · 2 employees · 2 known investors
SynsoryBio develops protein-based drugs that detect their location in the body and activate only at diseased tissue, with applications across cancer and autoimmune conditions.
Founders & leadership· Y Combinator alumni (W24)
ET
Elliot TagueinFounder
NT
Nathan TagueinFounder
Investors · 2
In the news
- SynsoryBio: Therapeutics that sense-and-respond to diseaseycombinator.com · 2024
